| Literature DB >> 31449816 |
Hilde Vrieling1, Sietske Kooijman2, Justin W de Ridder3, Dominique M E Thies-Weesie4, Peter C Soema3, Wim Jiskoot5, Elly van Riet3, Albert J R Heck6, Albert P Philipse4, Gideon F A Kersten1, Hugo D Meiring3, Jeroen L Pennings7, Bernard Metz8.
Abstract
Subunit vaccines often contain colloidal aluminum salt-based adjuvants to activate the innate immune system. These aluminum salts consist of micrometer-sized aggregates. It is well-known that particle size affects the adjuvant effect of particulate adjuvants. In this study, the activation of human monocytes by hexagonal-shaped gibbsite (ø = 210 ± 40 nm) and rod-shaped boehmite (ø = 83 ± 827 nm) was compared with classical aluminum oxyhydroxide adjuvant (alum). To this end, human primary monocytes were cultured in the presence of alum, gibbsite, or boehmite. The transcriptome and proteome of the monocytes were investigated by using quantitative polymerase chain reaction and mass spectrometry. Human monocytic THP-1 cells were used to investigate the effect of the particles on cellular maturation, differentiation, activation, and cytokine secretion, as measured by flow cytometry and enzyme-linked immunosorbent assay. Each particle type resulted in a specific gene expression profile. IL-1ß and IL-6 secretion was significantly upregulated by boehmite and alum. Of the 7 surface markers investigated, only CD80 was significantly upregulated by alum and none by gibbsite or boehmite. Gibbsite hardly activated the monocytes. Boehmite activated human primary monocytes equally to alum, but induced a much milder stress-related response. Therefore, boehmite was identified as a promising adjuvant candidate.Entities:
Keywords: alum; aluminum hydroxide; colloids; immune responses; proteomic; vaccine adjuvants
Mesh:
Substances:
Year: 2019 PMID: 31449816 DOI: 10.1016/j.xphs.2019.08.014
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534